Shapiro Aron 4
4 · KIORA PHARMACEUTICALS INC · Filed Feb 3, 2022
Insider Transaction Report
Form 4
Shapiro Aron
Director
Transactions
- Award
Stock Option (right to buy)
2022-02-01+5,000→ 5,000 totalExercise: $0.77Exp: 2032-02-01→ Common Stock (5,000 underlying)
Footnotes (1)
- [F1]The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become fully exercisable on February 1, 2023.